Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2005, p. 3025-3027, Vol. 49, No. 7
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.7.3025-3027.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
-Caprolactone) Microparticles
Centre de Recherche sur les Matériaux d'Intérêt Biologique, Equipe INSERM 99-03, UFR Odontologie,1 Laboratoire de Pharmacie Galénique, UFR de Pharmacie,2 UPRES EA 3826, UFR de Médecine, University of Nantes, 1 rue Gaston Veil, 44035 Nantes, France3
Received 18 October 2004/ Returned for modification 15 November 2004/ Accepted 23 March 2005
Treatment of methicillin-resistant Staphylococcus aureus osteomyelitis requires a prolonged antibiotic therapy with vancomycin. Because of its weak diffusion, the in situ implantation of vancomycin could be interesting. The activity of vancomycin encapsulated in microparticles was evaluated in vitro and in vivo on rabbit osteomyelitis and showed a good activity compared to intravenous administration.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»